Schedule 13G ownership disclosure

CERO THERAPEUTICS HLDGS INC

Common stock, par value $0.0001 per share · CUSIP: 71902K105

Event date: 2024-12-13

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • YK Bioventures Opportunities GP I, LLC

    Shares: 17,002.00 · Class: 0.0%

  • YK Bioventures Opportunities Fund I, L.P.

    Shares: 17,002.00 · Class: 0.0%

  • Gary K. Yeung

    Shares: 17,002.00 · Class: 0.0%

  • Mitchell W. Kossar

    Shares: 17,002.00 · Class: 0.0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001415889-24-029682
Form type
SCHEDULE 13G/A
Filer
CERO THERAPEUTICS HOLDINGS, INC.
CIK
CIK 1870404
Filed
Dec 17, 2024
Reporting period
Dec 13, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub